Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Drinks Industry News Technology Industry News Infosys to help soft drinks manufacturer Britvic in digital transformation Indian IT services provider Infosys said that it has been selected by European soft drinks manufacturer Britvic to… bySrinathMay 12, 2021
